Safety and effectiveness of ulotaront (SEP-363856) in schizophrenia: results of a 6-month, open-label extension study

por Correll, Christoph U., Koblan, Kenneth S., Hopkins, Seth C., Li, Yan, Heather Dworak, Goldman, Robert, Loebel, Antony
Publicado 2021